Fungal infection in heart-lung transplant recipients receiving single-agent prophylaxis with itraconazole

Don Hayes, Amanda M. Ball, Heidi - Mansour, Craig A. Martin, Jeremy D. Flynn

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Objectives: Heart and lung transplant recipients are at risk for invasive fungal infections. This study evaluated the affect of single-agent antifungal prophylaxis with itraconazole on the rate of fungal infections after heart or lung transplant. Materials and Methods: An observational, retrospective study was performed to evaluate the rate of fungal infections in heart and lung transplant recipients at the University of Kentucky Medical Center over 4.5 years who received itraconazole as a single therapy prophylaxis. Results: Eighty-three recipients (42 heart, 41 lung) had an overall fungal infection incidence of 16.9% (14/83), while the incidence was 11.9% for heart recipients (5/42), and 22.0% for lung recipients (9/41). Conclusions: Single-agent use with itraconazole in heart or lung transplant recipients did not affect the rate of fungal infection as compared with previous reports. The incidence of fungal infection increased significantly within 3 months after escalation of immunosuppressant for treatment of acute rejection.

Original languageEnglish (US)
Pages (from-to)399-404
Number of pages6
JournalExperimental and Clinical Transplantation
Volume9
Issue number6
StatePublished - Dec 2011
Externally publishedYes

Fingerprint

Itraconazole
Mycoses
Lung
Incidence
Antifungal Agents
Immunosuppressive Agents
Observational Studies
Transplant Recipients
Retrospective Studies
Transplants
Therapeutics

Keywords

  • Antifungal prophylaxis
  • Heart transplant
  • Itraconazole
  • Lung transplant

ASJC Scopus subject areas

  • Transplantation

Cite this

Fungal infection in heart-lung transplant recipients receiving single-agent prophylaxis with itraconazole. / Hayes, Don; Ball, Amanda M.; Mansour, Heidi -; Martin, Craig A.; Flynn, Jeremy D.

In: Experimental and Clinical Transplantation, Vol. 9, No. 6, 12.2011, p. 399-404.

Research output: Contribution to journalArticle

Hayes, Don ; Ball, Amanda M. ; Mansour, Heidi - ; Martin, Craig A. ; Flynn, Jeremy D. / Fungal infection in heart-lung transplant recipients receiving single-agent prophylaxis with itraconazole. In: Experimental and Clinical Transplantation. 2011 ; Vol. 9, No. 6. pp. 399-404.
@article{e6da2c67f9924c4dad08e16b7a90cd6b,
title = "Fungal infection in heart-lung transplant recipients receiving single-agent prophylaxis with itraconazole",
abstract = "Objectives: Heart and lung transplant recipients are at risk for invasive fungal infections. This study evaluated the affect of single-agent antifungal prophylaxis with itraconazole on the rate of fungal infections after heart or lung transplant. Materials and Methods: An observational, retrospective study was performed to evaluate the rate of fungal infections in heart and lung transplant recipients at the University of Kentucky Medical Center over 4.5 years who received itraconazole as a single therapy prophylaxis. Results: Eighty-three recipients (42 heart, 41 lung) had an overall fungal infection incidence of 16.9{\%} (14/83), while the incidence was 11.9{\%} for heart recipients (5/42), and 22.0{\%} for lung recipients (9/41). Conclusions: Single-agent use with itraconazole in heart or lung transplant recipients did not affect the rate of fungal infection as compared with previous reports. The incidence of fungal infection increased significantly within 3 months after escalation of immunosuppressant for treatment of acute rejection.",
keywords = "Antifungal prophylaxis, Heart transplant, Itraconazole, Lung transplant",
author = "Don Hayes and Ball, {Amanda M.} and Mansour, {Heidi -} and Martin, {Craig A.} and Flynn, {Jeremy D.}",
year = "2011",
month = "12",
language = "English (US)",
volume = "9",
pages = "399--404",
journal = "Experimental and Clinical Transplantation",
issn = "1304-0855",
publisher = "Baskent University",
number = "6",

}

TY - JOUR

T1 - Fungal infection in heart-lung transplant recipients receiving single-agent prophylaxis with itraconazole

AU - Hayes, Don

AU - Ball, Amanda M.

AU - Mansour, Heidi -

AU - Martin, Craig A.

AU - Flynn, Jeremy D.

PY - 2011/12

Y1 - 2011/12

N2 - Objectives: Heart and lung transplant recipients are at risk for invasive fungal infections. This study evaluated the affect of single-agent antifungal prophylaxis with itraconazole on the rate of fungal infections after heart or lung transplant. Materials and Methods: An observational, retrospective study was performed to evaluate the rate of fungal infections in heart and lung transplant recipients at the University of Kentucky Medical Center over 4.5 years who received itraconazole as a single therapy prophylaxis. Results: Eighty-three recipients (42 heart, 41 lung) had an overall fungal infection incidence of 16.9% (14/83), while the incidence was 11.9% for heart recipients (5/42), and 22.0% for lung recipients (9/41). Conclusions: Single-agent use with itraconazole in heart or lung transplant recipients did not affect the rate of fungal infection as compared with previous reports. The incidence of fungal infection increased significantly within 3 months after escalation of immunosuppressant for treatment of acute rejection.

AB - Objectives: Heart and lung transplant recipients are at risk for invasive fungal infections. This study evaluated the affect of single-agent antifungal prophylaxis with itraconazole on the rate of fungal infections after heart or lung transplant. Materials and Methods: An observational, retrospective study was performed to evaluate the rate of fungal infections in heart and lung transplant recipients at the University of Kentucky Medical Center over 4.5 years who received itraconazole as a single therapy prophylaxis. Results: Eighty-three recipients (42 heart, 41 lung) had an overall fungal infection incidence of 16.9% (14/83), while the incidence was 11.9% for heart recipients (5/42), and 22.0% for lung recipients (9/41). Conclusions: Single-agent use with itraconazole in heart or lung transplant recipients did not affect the rate of fungal infection as compared with previous reports. The incidence of fungal infection increased significantly within 3 months after escalation of immunosuppressant for treatment of acute rejection.

KW - Antifungal prophylaxis

KW - Heart transplant

KW - Itraconazole

KW - Lung transplant

UR - http://www.scopus.com/inward/record.url?scp=83455242885&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=83455242885&partnerID=8YFLogxK

M3 - Article

C2 - 22142048

AN - SCOPUS:83455242885

VL - 9

SP - 399

EP - 404

JO - Experimental and Clinical Transplantation

JF - Experimental and Clinical Transplantation

SN - 1304-0855

IS - 6

ER -